Manitoba is expanding eligibility for the second booster dose of COVID-19 vaccine to include:
- individuals aged 50 or older who live in the community (previously aged 70 or older);
- First Nations, Inuit and Métis people aged 30 or older, regardless of where they live (previously aged 50 or older);
- individuals aged 18 to 49 years who are moderately to severely immunocompromised (new); and
- residents of any age of personal care homes and elderly persons housing congregate living sites.
The province is also shortening the intervals to be eligible for booster doses. The first booster can now be given four months after the person’s primary vaccine series (usually two doses). The second booster dose can now be given four months after the first booster.
COVID-19 continues to circulate throughout the province and vaccination is the best protection against serious outcomes. It is not too late for people to receive their primary vaccine series or booster. To date, more than 590,000 first booster doses have been given to eligible people including nearly 80 per cent of those aged 60 and older. Nearly 10,000 people have received their second booster dose to date.
To find a location that offers the COVID-19 vaccine, Manitobans can use the online vaccine finder at www.manitoba.ca/covid19/vaccine/finder.html or call 1-844-626-8222 (toll-free).
Eligibility for COVID-19 treatment now includes adults who have symptoms that began within the last five to seven days, tested positive with either a rapid antigen or PCR test, and are at higher risk for severe illness because they:
- are not fully vaccinated;
- have not received a booster dose;
- have not been previously infected with COVID-19;
- are an older adult, as risk increases with age;
- have one or more chronic medical conditions;
- are moderately to severely immunocompromised, due to a medical condition or treatment;
- are obese; or
- are pregnant.
Some people who have received all of the vaccine doses they are eligible for may still be eligible for treatment if they are at higher risk for more severe outcomes for other reasons.
These criteria are broader than the requirements previously in place and people who may be eligible should speak with their health-care provider to determine which treatment may be right for them. Treatment criteria for young people under the age of 18 remains unchanged.
Paxlovid is an antiviral pill that can be prescribed to treat COVID-19 and is now more broadly available. Beginning today, people can fill their Paxlovid prescription at more than 175 community pharmacies across the province. A list of locations and more information is available at https://gov.mb.ca/covid19/treatment/paxlovid-locations.html.
For more information about COVID treatment, visit https://manitoba.ca/covid19/treatment.
To date, the Manitoba government has distributed 14.3 million rapid antigen tests. They continue to be available at libraries and retail locations across the province. A list of all participating retail locations, sorted by regional health authority, is now available at www.gov.mb.ca/covid19/testing/locations.html.
Manitoba continues to post weekly COVID-19 epidemiology reports at: www.gov.mb.ca/health/publichealth/surveillance/covid-19/index.html.
- COVID-19 in Manitoba: www.manitoba.ca/COVID19.
- Vaccine campaign: www.manitoba.ca/vaccine.
- Testing information: www.manitoba.ca/covid19/testing/index.html.
- Outbreaks: www.gov.mb.ca/covid19/prs/index.html.